翰思艾泰-B(03378)发布年度业绩净亏损1.31亿元同比扩大12.46%

智通财经03-27

智通财经APP讯，翰思艾泰-B(03378)发布截至2025年12月31日止财政年度全年业绩，集团其他收入及收益人民币1661.6万元，同比增长116.33%;研发开支8936.3万元，同比增加19.6%;净亏损1.31亿元，同比扩大12.46%。本公司核心竞争力源于聚焦独特的生物学原理和两大自主研发的专有生物新药创新平台 —VersatiBody™多功能抗体平台与autoRx40™自身免疫治疗...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2622814268?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-03-27 12:31","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2622814268","market":"hk","top_or_hot":-1,"title":"翰思艾泰-B(03378)发布年度业绩 净亏损1.31亿元 同比扩大12.46%","media":"智通财经","content":"<div>\n<p>智通财经APP讯，翰思艾泰-B(03378)发布截至2025年12月31日止财政年度全年业绩，集团其他收入及收益人民币1661.6万元，同比增长116.33%;研发开支8936.3万元，同比增加19.6%;净亏损1.31亿元，同比扩大12.46%。本公司核心竞争力源于聚焦独特的生物学原理和两大自主研发的专有生物新药创新平台 —VersatiBody™多功能抗体平台与autoRx40™自身免疫治疗...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1420276.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>翰思艾泰-B(03378)发布年度业绩 净亏损1.31亿元 同比扩大12.46%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n翰思艾泰-B(03378)发布年度业绩 净亏损1.31亿元 同比扩大12.46%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-03-27 12:31 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1420276.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP讯，翰思艾泰-B(03378)发布截至2025年12月31日止财政年度全年业绩，集团其他收入及收益人民币1661.6万元，同比增长116.33%;研发开支8936.3万元，同比增加19.6%;净亏损1.31亿元，同比扩大12.46%。本公司核心竞争力源于聚焦独特的生物学原理和两大自主研发的专有生物新药创新平台 —VersatiBody™多功能抗体平台与autoRx40™自身免疫治疗...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1420276.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1173","symbol_name":"海港与服务","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1420276.html","article_id":"2622814268","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2622814268","pubTimestamp":1774585900,"columns":[{"name":"行业数据","id":30,"label_key":"dataReport"}],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP讯，翰思艾泰-B 发布截至2025年12月31日止财政年度全年业绩，集团其他收入及收益人民币1661.6万元，同比增长116.33%;研发开支8936.3万元，同比增加19.6%;净亏损1.31亿元，同比扩大12.46%。截至2025年12月31日，本公司已建立“临床阶段(3款)+IND批准阶段(1款)+临床前阶段(多款)”的阶梯式产品管线布局，其中肿瘤免疫双特异性抗体、OX40靶向ADC等核心资产具备全球FIC潜力，为本公司长期发展奠定坚实的产品基础。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK1173":"海港与服务","03378":"翰思艾泰-B","BK1161":"生物科技","BK1535":"港口运输股"},"translate_title":"Hansi Aitai-B (03378) released its annual results with a net loss of 131 million yuan, an increase of 12.46% year-on-year","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03378":1.5},"content_text":"智通财经APP讯，翰思艾泰-B(03378)发布截至2025年12月31日止财政年度全年业绩，集团其他收入及收益人民币1661.6万元，同比增长116.33%;研发开支8936.3万元，同比增加19.6%;净亏损1.31亿元，同比扩大12.46%。本公司核心竞争力源于聚焦独特的生物学原理和两大自主研发的专有生物新药创新平台 —VersatiBody™多功能抗体平台与autoRx40™自身免疫治疗平台，以此协同驱动差异化候选药物的高效研发与输出，同时通过内部自主研发+外部战略合作的双轮模式，持续丰富产品管线、加速临床开发进程、放大技术平台商业价值。截至2025年12月31日，本公司已建立“临床阶段(3款)+IND批准阶段(1款)+临床前阶段(多款)”的阶梯式产品管线布局，其中肿瘤免疫双特异性抗体、OX40靶向ADC等核心资产具备全球FIC潜力，为本公司长期发展奠定坚实的产品基础。2025年，本公司围绕管线临床推进、技术平台迭代、全球化布局完成多项关键里程碑，核心资产临床价值初步验证，为股东创造了阶段性价值。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"dataReport","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2622814268","isCrawlerRequest":true}

翰思艾泰-B(03378)发布年度业绩 净亏损1.31亿元 同比扩大12.46%

精彩评论

翰思艾泰-B(03378)发布年度业绩净亏损1.31亿元同比扩大12.46%